Earlier in the day, the health agency allowed 10 million doses to be distributed in the U.S. to other countries, but with a caveat that there is no guarantee the J&J shots wee made under good manufacturing practices.
The FDA records - released as part of the House report - described the plant as a contract testing laboratory that 'did not manufacture products for distribution.'
Further, the inspection also noted there was 'mold, poor disinfection of plant equipment and inadequate training of employees'.
From the article:
The last quote was just for funsies.